Holen Sie sich die Stockscreener-App
8.745
9.14%
0.645
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax earnings in focus: Safety edge meets steep revenue test By Investing.com - Investing.com Nigeria
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates? - TradingView
Attachment - GlobeNewswire
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Novavax, Inc. (NVAX) A Good Stock To Buy Now? - Insider Monkey
Vanguard reports 8.31M-share stake in Novavax (NVAX) - Stock Titan
Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Novavax investors get first-quarter 2026 results at 8:30 a.m. May 6 - Stock Titan
Novavax, Inc. (NVAX) is attracting investor attention: Here is what you should know - MSN
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Novavax (NVAX) director exercises RSUs for 9,520 common shares - Stock Titan
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax Q2 2025 Earnings Preview - MSN
Bank of America reports 4.1% Novavax stake (NASDAQ: NVAX) - Stock Titan
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novavax (NASDAQ: NVAX) details 2026 proxy, board slate and equity share increases - Stock Titan
Novavax Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Novavax Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
NVAX stock rises overnight ahead of Q4 print with Pfizer tailwinds — analyst warns of 20% crash - MSN
Novavax Soars After Covid Vaccine Secures Full FDA Approval - MSN
Avoiding Lag: Real-Time Signals in (NVAX) Movement - Stock Traders Daily
Novavax Q3 2025 Earnings Preview - MSN
Cash-Rich Stocks: 10x Genomics, Novavax, and Powell Analysis | April 2026News and Statistics - IndexBox
Is Novavax (NVAX) Now Pricing In Too Much Risk After Its Recent Volatility - Yahoo Finance
Therapeutics Stocks Q4 Earnings: AbbVie and Novavax Performance Analysis as of April 2026News and Statistics - IndexBox
Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead - Insider Monkey
FY2028 EPS Estimates for Novavax Cut by Zacks Research - MarketBeat
1 Cash-Heavy Stock to Target This Week and 2 We Ignore - The Globe and Mail
Novavax (NVAX) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Earnings snapshot: Novavax tops Q2 estimates; raises full-year outlook - MSN
5 Most Undervalued Healthcare Stocks to Buy Now - Insider Monkey
Is Novavax (NVAX) stock a good investment this year | Novavax Inc. posts 122% EPS beat vs expected lossProfit Guidance - Xã Thanh Hà
US CDC will not publish report showing COVID vaccine effectiveness - Reuters
COVID vaccine report on cutting hospital visits blocked from publication in CDC journal - Seeking Alpha
Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs? - TradingView
Will Higher Costs & Lower Occupancy Impact HCA's Q1 Earnings? - TradingView
Therapeutics Q4 Earnings: Novavax (NASDAQ:NVAX) Simply the Best - Yahoo Finance
H.C. Wainwright reiterates Novavax stock rating on vaccine study By Investing.com - Investing.com India
H.C. Wainwright reiterates Novavax stock rating on vaccine study - Investing.com
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In - MedCity News
Novavax’s COVID vaccine becomes 4th available for use in Japan - 朝日新聞
Novavax Urged to Probe Studies Using Monkeys From Filthy Lab After PETA Exposé - PETA
Novavax (NVAX) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Novavax (NVAX) EVP R&D discloses options, RSUs and shares on Form 3 - Stock Titan
Discipline and Rules-Based Execution in NVAX Response - Stock Traders Daily
Novavax Inc stock (US6707721049): Is its vaccine pipeline strong enough to unlock new upside? - AD HOC NEWS
SHAH CAPITAL MANAGEMENT Increases Stake in Novavax Inc - GuruFocus
Novavax Inc stock (US6707721049): Is its vaccine pivot strong enough to unlock new upside? - AD HOC NEWS
0.78%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):